1. Ahn K, Johnson DS, Fitzgerald LR, Liimatta M, Arendse A, Stevenson T, Lund ET, Nugent RA, Nomanbhoy TK, Alexander JP et al.. (2007) Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity.
Biochemistry, 46 (45): 13019-30.
[PMID:17949010]
2. Ahn K, Johnson DS, Mileni M, Beidler D, Long JZ, McKinney MK, Weerapana E, Sadagopan N, Liimatta M, Smith SE et al.. (2009) Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain.
Chem. Biol., 16 (4): 411-20.
[PMID:19389627]
3. Karbarz MJ, Luo L, Chang L, Tham CS, Palmer JA, Wilson SJ, Wennerholm ML, Brown SM, Scott BP, Apodaca RL et al.. (2009) Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
Anesth. Analg., 108 (1): 316-29.
[PMID:19095868]
4. Keith JM, Apodaca R, Xiao W, Seierstad M, Pattabiraman K, Wu J, Webb M, Karbarz MJ, Brown S, Wilson S et al.. (2008) Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase.
Bioorg. Med. Chem. Lett., 18 (17): 4838-43.
[PMID:18693015]
5. Liu Q, Tonai T, Ueda N. (2002) Activation of N-acylethanolamine-releasing phospholipase D by polyamines.
Chem. Phys. Lipids, 115 (1-2): 77-84.
[PMID:12047899]
6. Petersen G, Hansen HS. (1999) N-acylphosphatidylethanolamine-hydrolysing phospholipase D lacks the ability to transphosphatidylate.
FEBS Lett., 455 (1-2): 41-4.
[PMID:10428468]
7. Ribeiro A, Pontis S, Mengatto L, Armirotti A, Chiurchiù V, Capurro V, Fiasella A, Nuzzi A, Romeo E, Moreno-Sanz G et al.. (2015) A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.
ACS Chem. Biol., 10 (8): 1838-46.
[PMID:25874594]
8. Solorzano C, Zhu C, Battista N, Astarita G, Lodola A, Rivara S, Mor M, Russo R, Maccarrone M, Antonietti F et al.. (2009) Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
Proc. Natl. Acad. Sci. U.S.A., 106 (49): 20966-71.
[PMID:19926854]
9. Tsuboi K, Hilligsmann C, Vandevoorde S, Lambert DM, Ueda N. (2004) N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.
Biochem. J., 379 (Pt 1): 99-106.
[PMID:14686878]
10. Tsuboi K, Ikematsu N, Uyama T, Deutsch DG, Tokumura A, Ueda N. (2013) Biosynthetic pathways of bioactive N-acylethanolamines in brain.
CNS Neurol Disord Drug Targets, 12 (1): 7-16.
[PMID:23394527]
11. Ueda N, Yamanaka K, Yamamoto S. (2001) Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance.
J. Biol. Chem., 276 (38): 35552-7.
[PMID:11463796]
12. Wei BQ, Mikkelsen TS, McKinney MK, Lander ES, Cravatt BF. (2006) A second fatty acid amide hydrolase with variable distribution among placental mammals.
J. Biol. Chem., 281 (48): 36569-78.
[PMID:17015445]
Routes for N-acylethanolamine biosynthesis other than through NAPE-PLD activity have been identified [10].